Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115338592 | 11533859 | 2 | F | 201508 | 20160729 | 20150922 | 20160805 | EXP | US-AMGEN-USASP2015095966 | AMGEN | 57.00 | YR | A | F | Y | 83.90000 | KG | 20160805 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115338592 | 11533859 | 1 | PS | XGEVA | DENOSUMAB | 1 | Unknown | UNK UNK, QMO | 125320 | UNKNOWN FORMULATION | /month | ||||||||
| 115338592 | 11533859 | 2 | SS | IBRANCE | PALBOCICLIB | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 115338592 | 11533859 | 3 | SS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, QD | 0 | 25 | MG | QD | |||||||
| 115338592 | 11533859 | 4 | SS | NEURONTIN | GABAPENTIN | 1 | Oral | 300 MG, BID | 0 | 300 | MG | BID | |||||||
| 115338592 | 11533859 | 5 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | UNK | 0 | |||||||||||
| 115338592 | 11533859 | 6 | C | CHLOROPHYLL | 2 | Oral | 100 MG, QD | 0 | 100 | MG | QD | ||||||||
| 115338592 | 11533859 | 7 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 115338592 | 11533859 | 8 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | UNK | 0 | |||||||||||
| 115338592 | 11533859 | 9 | C | NOVOLOG | INSULIN ASPART | 1 | 100 UNIT/ML, BEFORE EACH MEAL | 0 | |||||||||||
| 115338592 | 11533859 | 10 | C | LANTUS | INSULIN GLARGINE | 1 | 100 UNIT/ML, QD | 0 | QD | ||||||||||
| 115338592 | 11533859 | 11 | C | PRINIVIL | LISINOPRIL | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 115338592 | 11533859 | 12 | C | NOLVADEX | TAMOXIFEN CITRATE | 1 | UNK, QD | 0 | QD | ||||||||||
| 115338592 | 11533859 | 13 | C | WARFARIN | WARFARIN | 1 | 5 MG ON MONDAY, THURSDAY AND 7.5 MG FOR ALL OTHER DAYS | 0 | |||||||||||
| 115338592 | 11533859 | 14 | C | FEMARA | LETROZOLE | 1 | UNK | 0 | |||||||||||
| 115338592 | 11533859 | 15 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 1000 UNIT, QD | 0 | QD | |||||||||
| 115338592 | 11533859 | 16 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Oral | 10 MG, TID | 0 | 10 | MG | TID | |||||||
| 115338592 | 11533859 | 17 | C | EVEROLIMUS | EVEROLIMUS | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 115338592 | 11533859 | 18 | C | FISH OIL | FISH OIL | 1 | Oral | 1000 MG, QD | 0 | 1000 | MG | QD | |||||||
| 115338592 | 11533859 | 19 | C | DELTASONE | PREDNISONE | 1 | 20 MG, 1 TID FOR 2 DAYS, BID FOR 2 DAYS AND QD FOR 2 DAYS | 0 | 20 | MG | |||||||||
| 115338592 | 11533859 | 20 | C | COMPAZINE | PROCHLORPERAZINE MALEATE | 1 | Oral | 10 MG, Q6H | 0 | 10 | MG | QID | |||||||
| 115338592 | 11533859 | 21 | C | COMPAZINE | PROCHLORPERAZINE MALEATE | 1 | 0 | ||||||||||||
| 115338592 | 11533859 | 22 | C | COLACE | DOCUSATE SODIUM | 1 | Oral | 100 MG, UNK | 0 | 100 | MG | ||||||||
| 115338592 | 11533859 | 23 | C | ZESTRIL | LISINOPRIL | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 115338592 | 11533859 | 24 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | 2 MG, UNK | 0 | 2 | MG | |||||||||
| 115338592 | 11533859 | 25 | C | PNEUMOCOCCAL POLYSACCHARIDE VACCINE | PNEUMOCOCCAL VACCINE POLYVALENT | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115338592 | 11533859 | 1 | Metastases to bone |
| 115338592 | 11533859 | 2 | Product used for unknown indication |
| 115338592 | 11533859 | 3 | Product used for unknown indication |
| 115338592 | 11533859 | 4 | Product used for unknown indication |
| 115338592 | 11533859 | 13 | Ovarian vein thrombosis |
| 115338592 | 11533859 | 20 | Nausea |
| 115338592 | 11533859 | 21 | Vomiting |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115338592 | 11533859 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115338592 | 11533859 | Acute kidney injury | |
| 115338592 | 11533859 | Asthenia | |
| 115338592 | 11533859 | Back pain | |
| 115338592 | 11533859 | Cellulitis | |
| 115338592 | 11533859 | Cholelithiasis | |
| 115338592 | 11533859 | Fatigue | |
| 115338592 | 11533859 | Gastric disorder | |
| 115338592 | 11533859 | Headache | |
| 115338592 | 11533859 | Heart rate increased | |
| 115338592 | 11533859 | Hepatic steatosis | |
| 115338592 | 11533859 | Localised infection | |
| 115338592 | 11533859 | Neck pain | |
| 115338592 | 11533859 | Ovarian vein thrombosis | |
| 115338592 | 11533859 | Pain | |
| 115338592 | 11533859 | Wheelchair user |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115338592 | 11533859 | 1 | 2012 | 0 | ||
| 115338592 | 11533859 | 3 | 20160615 | 0 | ||
| 115338592 | 11533859 | 12 | 20150128 | 0 | ||
| 115338592 | 11533859 | 14 | 20150128 | 0 | ||
| 115338592 | 11533859 | 17 | 20160615 | 0 | ||
| 115338592 | 11533859 | 25 | 20150215 | 0 |